Professor Zhang Aimin – Academic Exchange & Clinical Guidance at Our Hospital

Professor Zhang Aimin – Academic Exchange & Clinical Guidance at Our Hospital

On June 13, Professor Zhang Aimin from the Department of Pain Medicine at Sichuan Cancer Hospital – the affiliated cancer hospital of the University of Electronic Science and Technology of China – visited the Department of Pain Medicine at Gansu Wuwei Cancer Hospital. During his visit, he conducted consultations on complex pain cases, provided guidance on minimally invasive interventional procedures, led teaching rounds, and delivered academic lectures. Drawing on his expertise in comprehensive cancer pain management and advanced minimally invasive interventional techniques for chronic pain, Professor Zhang helped elevate the hospital's pain medicine capabilities to a higher level, bringing high‑quality, patient‑centered care to patients in the Hexi region who suffer from cancer pain, neuropathic pain, and other forms of intractable chronic pain.

Professor Zhang Aimin is a physician with an MD, a Deputy Chief Physician, and a post‑doctoral researcher. He currently serves as Vice Chair (and Chair‑elect) of the Refractory Cancer Pain Committee of the Sichuan Medical Innovation and Research Association. He is also a member of the Cancer Pain Integrated Treatment Committee of the China Anti‑Cancer Association, the Palliative Care Professional Committee of the China Narcotics Drug Association, and the Tumor Symptom Management Expert Committee of the China Medical Development Foundation. He serves as a young editorial board member for APS (the journal of the American Pain Society), a standing committee member of the Tumor Pain Branch of the Sichuan Anti‑Cancer Association, and a member of the Pain Professional Committee of the Chengdu Medical Association. With years of experience in clinical pain practice, teaching, and research, Professor Zhang has deep expertise in minimally invasive interventional diagnosis and treatment for refractory cancer pain, neuropathic pain, spinal‑origin pain, and complex pain syndromes such as post‑herpetic neuralgia and trigeminal neuralgia. He is a highly influential young leading expert in the field of minimally invasive interventional pain medicine in China.

During the complex case consultations, Professor Zhang Aimin worked with our pain medicine team to discuss a series of challenging pain cases. He carefully reviewed each patient's medical history and prior treatment records, providing systematic guidance on comprehensive pain management, standardized medication use, evaluation of indications for minimally invasive interventional treatments, and holistic patient care.

During the teaching rounds, Professor Zhang Aimin conducted bedside interviews and physical examination demonstrations. Using specific cases, he provided hands‑on instruction on pain assessment methods, pharmacological treatment adjustments, and multidisciplinary collaboration models, helping junior physicians further refine their clinical reasoning in a standardized manner.

Professor Zhang Aimin's visit marks a key step in our hospital's efforts to bring in high‑quality medical resources, address gaps in pain medicine, and enhance the service capacity of key specialties. This engagement has significantly advanced our pain department's alignment with leading national standards in standardized refractory cancer pain management, minimally invasive interventional techniques for chronic pain, and multidisciplinary collaboration models. Looking ahead, Gansu Wuwei Cancer Hospital will continue to invite nationally recognized experts for outpatient consultations, surgical guidance, and academic exchanges. We will strengthen the development of key specialty disciplines, deepen innovation in minimally invasive interventions and precision analgesia, and strive to alleviate suffering for patients in pain through more advanced techniques and more compassionate care, safeguarding the health and well‑being of people across Northwest China.

Writer: Yang Yang

First Reviewer: Yang Yang

Second Reviewer: Guo Yishan

Third Reviewer: Cai Qinghua

Wuwei Cancer Hospital of Gansu Province (Wuwei Institute of Medical Sciences)

（甘）医广【2025】第11-14-387号